SEC 13F Intelligence

Boxer Capital, LLC / RLMD

Boxer Capital, LLC’s Relmada Therapeutics Inc Position

Does Boxer Capital, LLC own Relmada Therapeutics Inc (RLMD)? Not currently — the last reported position was 300.0K shares worth $11M in Q3 2020; the fund’s latest 13F (Q4 2024) no longer reports it.

Position Value
$11M
Q3 2020
Shares
300.0K
% of Portfolio
+0.39%
Quarters Held
4
position exited

Position History RLMD

Reported value by quarter
Q4 ’19: $12MQ4 ’19Q1 ’20: $10MQ1 ’20Q2 ’20: $13MQ2 ’20Q3 ’20: $11MQ3 ’20filingsflow.com
QuarterSharesValue% of Portfolio
Q3 2020300.0K$11M+0.39%
Q2 2020300.0K$13M+0.59%
Q1 2020300.0K$10M+0.70%
Q4 2019300.0K$12M+0.66%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Boxer Capital, LLC’s full portfolio or all institutional holders of RLMD.